Witnessing the stock’s movement on the chart, on November 20, 2020, Heat Biologics Inc. (NASDAQ: HTBX) had a quiet start as it plunged -0.98% to $1.01. During the day, the stock rose to $1.02 and sunk to $0.99 before settling in for the price of $1.02 at the close. Taking a more long-term approach, HTBX posted a 52-week range of $0.19-$4.30.
Meanwhile, its Annual Earning per share during the time was 49.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.20%. This publicly-traded company’s shares outstanding now amounts to $159.85 million, simultaneously with a float of $155.02 million. The organization now has a market capitalization sitting at $163.00 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1994, while the 200-day Moving Average is $1.0306.
While finding the extent of efficiency of the company that is accounted for 36 employees. It has generated 84,697 per worker during the last fiscal year. Meanwhile, its income per employee was -556,044. The stock had 96.00 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -636.11 and Pretax Margin of -667.07.
Heat Biologics Inc. (HTBX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Heat Biologics Inc.’s current insider ownership accounts for 3.01%, in contrast to 12.00% institutional ownership. According to the most recent insider trade that took place on Nov 12, this organization’s Director sold 103,304 shares at the rate of 1.03, making the entire transaction reach 106,403 in total value, affecting insider ownership by 0.
Heat Biologics Inc. (HTBX) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.06 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.03) by -$0.03. This company achieved a net margin of -656.51 while generating a return on equity of -91.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
Heat Biologics Inc.’s EPS increase for this current 12-month fiscal period is 33.20% and is forecasted to reach -0.23 in the upcoming year.
Heat Biologics Inc. (NASDAQ: HTBX) Trading Performance Indicators
Let’s observe the current performance indicators for Heat Biologics Inc. (HTBX). It’s Quick Ratio in the last reported quarter now stands at 31.30. The Stock has managed to achieve an average true range (ATR) of 0.07. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 37.91.
In the same vein, HTBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.32, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of Heat Biologics Inc. (HTBX)
Going through the that latest performance of [Heat Biologics Inc., HTBX]. Its last 5-days volume of 3.75 million was inferior to the volume of 15.99 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 43.07% While, its Average True Range was 0.0589.
Raw Stochastic average of Heat Biologics Inc. (HTBX) in the period of the previous 100 days is set at 5.70%, which indicates a major fall in contrast to 28.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 43.27% that was lower than 124.77% volatility it exhibited in the past 100-days period.
Heat Biologics Inc. (NASDAQ: HTBX), Heat Biologics Inc., (HTBX), NASDAQ: HTBX, HTBX Shares, HTBX Stock, HTBX